Legal & General Group PLC Precision Biosciences Inc Transaction History

Legal & General Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $75,343 - $2.52 Million	-61,757 Reduced 93.39%	4,373 $6,000
Q2 2022 Aug 22, 2022	BUY	$1.15 - $3.34 $44,899 - $130,403	39,043 Added 144.14%	66,130 $106,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $828 - $1,305	112 Added 0.42%	27,087 $200,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $85,401 - $131,637	9,303 Added 52.64%	26,975 $311,000
Q2 2021 Aug 12, 2021	BUY	$8.07 - $12.52 $91,126 - $141,375	11,292 Added 176.99%	17,672 $221,000
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $4,756 - $8,763	-555 Reduced 8.0%	6,380 $66,000
Q4 2020 Feb 12, 2021	BUY	$5.98 - $12.47 $7,803 - $16,273	1,305 Added 23.18%	6,935 $58,000
Q3 2020 Nov 13, 2020	SELL	$4.65 - $8.73 $8,309 - $15,600	-1,787 Reduced 24.09%	5,630 $35,000
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $6,868 - $12,823	1,474 Added 24.8%	7,417 $62,000
Q1 2020 May 14, 2020	SELL	$5.05 - $15.01 $7,428 - $22,079	-1,471 Reduced 19.84%	5,943 $36,000
Q4 2019 Feb 13, 2020	BUY	$6.32 - $19.66 $37,376 - $116,269	5,914 Added 394.27%	7,414 $103,000
Q2 2019 Aug 14, 2019	SELL	$11.88 - $16.94 $29,700 - $42,350	-2,500 Reduced 62.5%	1,500 $20,000
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $69,760 - $71,800	4,000 New	4,000 $70,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $552M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.